welcome to cyprotex adme
welcome to cyprotex adme
cloe predict
cloe select
cloe screen
home > ADME and PK services > cloe select > pKa and log P determination

pKa and log P

Understand the physicochemical properties of your compound by using our pKa and Log P service.

The determination of pKa and log P is offered within our Cloe Select portfolio of in vitro experimental services. Cyprotex deliver consistent, high quality data with the flexibility to adapt protocols based on specific customer requirements.

The measurement of pKa and log P

  • The pKa of a molecule is the pH at which the molecule is 50 % protonated.
  • Log P (or partition co-efficient) is a measure of the lipophilicity of a compound.
  • Cloe Select pKa and log P determination uses a pH-metric GLpKa technology developed by Sirius. This is considered to be a ‘gold standard’ method for determining these properties.
  • In pH-metric methods, pKa is measured by titrating a solution of the sample in water or solvent with acid and base, and calculating the pKa from comparing the shape of the titration curve with that of a blank titration, in the absence of test compound. Log P is also measured by a pH-metric method, based on a two-phase acid-base titration in the presence of octanol.
  • GLpKa supports six partition solvents including octanol, and eight co-solvents including methanol and DMSO.
 
 
‘pKa affects solubility, permeability, log D and oral absorption by modulating the distribution of neutral and charged species.’
1Di L and Kerns EH. (2003) Current Opinion in Chemical Biology: 7, 402-408.
Protocol +
Data +
Q&A +
References

1 Di L and Kerns EH. (2003) Current Opinion in Chemical Biology 7; 402-408.
2 Lewis DF. (2000) Biochem Pharmacol 60: 293-306.

3 Urien S et al. (2001) In Pharmacokinetic optimisation in drug research Ed. Testa et al 189-197
4 Timbrell JA. (1991) In Principles of Biochemical Toxicology 65-67

 
pKa and log P determination

Download a copy of the product sheet

Cloe® is a registered trade mark owned by Cyprotex PLC

careerscontactlegalprivacy
This website was last updated
on 3rd February 2012
This website is intended to assist investors, industry participants, customers and employees to understand Cyprotex’s global operations and ambitions.
Certain information and detail is disclosed in the interest of compliance of AIM Rule 26.